University of Antwerp - Multidisciplinary Oncologic Centre Antwerp (MOCA), University of Antwerp, University of Antwerp, University of Antwerp, Sciensano, University of Antwerp - Antwerp University Hospital (UZA), University of Antwerp, University of Antwerp, University of Antwerp, University of Antwerp - Antwerp University Hospital (UZA), Université Libre de Bruxelles (ULB) - ULB Center for Research in Immunology (U-CRI), Sciensano, University of Antwerp - Department of Clinical Sciences, AZ Delta General Hospital - AZ Delta Medical Laboratories, Sciensano, University of Antwerp, Sciensano, University of Antwerp, Sciensano, University of Antwerp and University of Antwerp

Université Libre de Bruxelles, KU Leuven - Department of Microbiology & Immunology, University of Cambridge, Université Libre de Bruxelles (ULB), KU Leuven, Université Libre de Bruxelles (ULB), Université Libre de Bruxelles (ULB) - ULB Center for Research in Immunology (U-CRI), Sciensano, Université Libre de Bruxelles (ULB), Université Libre de Bruxelles (ULB), Université Libre de Bruxelles (ULB), KU Leuven, KU Leuven, Université Libre de Bruxelles (ULB), Université Libre de Bruxelles (ULB) - Department of Infectious Disease, Université Libre de Bruxelles (ULB) - Centre for Environmental Health and Occupational Health, Sciensano, Sciensano, Babraham Institute, KU Leuven, Université Libre de Bruxelles (ULB) - ULB Center for Research in Immunology (U-CRI), Université Libre de Bruxelles (ULB), Université Libre de Bruxelles (ULB) - ULB Center for Research in Immunology (U-CRI), The Babraham Institute - Immunology Programme and KU Leuven - Department of Microbiology & Immunology